Understanding breathing difficulties in children
Multidimensional Characterization of Dyspnea in Children
This study aims to see how breathing difficulties affect children aged 6-17 with conditions like asthma and cystic fibrosis to help improve their care and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 6 Years to 17 Years |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT05500833 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate dyspnea in children using a multidimensional observation scale. The researchers hypothesize that this approach will provide a more systematic and precise assessment of respiratory discomfort in pediatric patients. By focusing on both acute and chronic respiratory insufficiency, the study seeks to improve management and follow-up care for children experiencing conditions like asthma and cystic fibrosis. The study will involve children aged 6-17 who are experiencing respiratory complaints and are being treated at a specialized pediatric pulmonology department.
Who should consider this trial
Good fit: Ideal candidates are children aged 6-17 years with respiratory complaints, including those with acute and chronic respiratory insufficiency.
Not a fit: Patients with cognitive disorders that prevent them from understanding self-assessment scales will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management strategies for children suffering from respiratory difficulties.
How similar studies have performed: Previous studies in adults have shown that multidimensional dyspnea evaluation scales correlate well with quality of life and respiratory function, suggesting potential success in this pediatric approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged between 6-17 years old at inclusion * Experiencing respiratory complaints at inclusion * Social security number * Children whom parents or legal representatives are present or reachable via phone call at inclusion * Non-opposition of parents or legal representatives to participate in the study * Children who are followed at or hospitalized in Trousseau hospital's pediatric pulmonology department for: asthma attack, acute respiratory insufficiency, acute exacerbation of a chronic respiratory disease, chronic respiratory insufficiency. * For the study of acute dyspnea: patients hospitalized for acute respiratory disease since less than 72h. * For the study of chronic dyspnea: children presenting with chronic respiratory disease. Exclusion Criteria: * Cognitive disorders making it impossible to understand self-assessment scales * Refusal of the child to participate in the research For the assessment of chronic dyspnea: * Children followed for a chronic respiratory pathology having presented an episode of acute respiratory decompensation in the 6 weeks preceding inclusion.
Where this trial is running
Paris
- Service de pneumologie pédiatrique, Hôpital Armand Trousseau — Paris, France (Recruiting)
Study contacts
- Study coordinator: Jessica TAYTARD, MD, PhD
- Email: jessica.taytard@aphp.fr
- Phone: +33677855889
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.